S9 Impact of Pancreatic Divisum on Inpatient Outcomes in Pancreatitis: A Nationwide Analysis

Introduction: Pancreatic divisum (PD) is the most common congenital anomaly of the pancreatic ductal system, occurring in up to 10% of the population. While most patients with PD are asymptomatic, it has been implicated as a potential risk factor for recurrent or idiopathic pancreatitis. We sought to evaluate whether patients admitted for management of pancreatitis secondary to PD had disparate outcomes compared to those without. Methods: We analyzed 5-year data from the National Inpatient Sample from 2018 to 2022 to identify adult hospitalizations with a primary diagnosis of acute or chronic pancreatitis using relevant ICD-10 codes. PD was identified in the secondary diagnosis field. In-hospital mortality, length of stay, total hospital charges, and intensive care unit (ICU) utilization were outcomes of interest. Results: Among an estimated 366,053 weighted pancreatitis admissions, 0.48% had a secondary diagnosis of coexisting pancreatic divisum. Compared to non-PD cases, PD patients were younger (mean age 49.9 vs 50.9) and had a lower prevalence of alcohol use (11.8% vs 33.6%), gallstones (5.8% vs 15.3%), and obesity (15.3% vs 19.1%), all P < 0.001. When adjusted for confounders, PD was associated with increased length of stay (+0.67 days, P < 0.001) and higher total charges (+$6,479, P = 0.004) but showed no significant difference in in-hospital mortality (adjusted odds ratio 0.40, P = 0.083) or ICU use (adjusted odds ratio 0.60, P = 0.052). Conclusion: In this large cohort study, PD was found to account for a small subset of patients with pancreatitis. Although these patients experienced longer hospital stays and higher procedural costs, pancreatic divisum was not associated with poorer short-term outcomes, although there was a trend toward significance, particularly with respect to ICU use. The higher costs and extended hospital stays were likely a result of the more extensive diagnostic workups, performed to rule out other causes prior to determining PD as the primary etiology.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001126496.64896.15
Primary Topic
Healthcare cost, quality, practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S9 Impact of Pancreatic Divisum on Inpatient Outcomes in Pancreatitis: A Nationwide Analysis

Rahul Shekhar, Nathan Tofteland, Mohamed Omar, William J. Salyers et al.
The American Journal of Gastroenterology
Healthcare cost, quality, practices
article

S9 Impact of Pancreatic Divisum on Inpatient Outcomes in Pancreatitis: A Nationwide Analysis

Rahul Shekhar, Nathan Tofteland, Mohamed Omar, William J. Salyers, Kyle Rowe, Hayder Alamily, David Maundu
article en

Abstract

Introduction: Pancreatic divisum (PD) is the most common congenital anomaly of the pancreatic ductal system, occurring in up to 10% of the population. While most patients with PD are asymptomatic, it has been implicated as a potential risk factor for recurrent or idiopathic pancreatitis. We sought to evaluate whether patients admitted for management of pancreatitis secondary to PD had disparate outcomes compared to those without. Methods: We analyzed 5-year data from the National Inpatient Sample from 2018 to 2022 to identify adult hospitalizations with a primary diagnosis of acute or chronic pancreatitis using relevant ICD-10 codes. PD was identified in the secondary diagnosis field. In-hospital mortality, length of stay, total hospital charges, and intensive care unit (ICU) utilization were outcomes of interest. Results: Among an estimated 366,053 weighted pancreatitis admissions, 0.48% had a secondary diagnosis of coexisting pancreatic divisum. Compared to non-PD cases, PD patients were younger (mean age 49.9 vs 50.9) and had a lower prevalence of alcohol use (11.8% vs 33.6%), gallstones (5.8% vs 15.3%), and obesity (15.3% vs 19.1%), all P < 0.001. When adjusted for confounders, PD was associated with increased length of stay (+0.67 days, P < 0.001) and higher total charges (+$6,479, P = 0.004) but showed no significant difference in in-hospital mortality (adjusted odds ratio 0.40, P = 0.083) or ICU use (adjusted odds ratio 0.60, P = 0.052). Conclusion: In this large cohort study, PD was found to account for a small subset of patients with pancreatitis. Although these patients experienced longer hospital stays and higher procedural costs, pancreatic divisum was not associated with poorer short-term outcomes, although there was a trend toward significance, particularly with respect to ICU use. The higher costs and extended hospital stays were likely a result of the more extensive diagnostic workups, performed to rule out other causes prior to determining PD as the primary etiology.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 52%
Healthcare cost, quality, practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.